Blood and Lymphatic Cancer: Targets and Therapy (BLC:TT)

Blood and Lymphatic Cancer: Targets and Therapy is an international, peer reviewed, open access journal focusing on blood and lymphatic cancer research, identification of therapeutic targets, and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for the cancer patient. Blood and Lymphatic Cancer: Targets and Therapy will no longer consider meta-analyses for publication. Specific topics covered in the journal include: Epidemiology, detection and screening Cellular research and biomarkers Identification of biotargets and agents with novel mechanisms of action Optimal clinical use of existing anticancer agents, including combination therapies Radiation, surgery, bone marrow transplantation Palliative care Patient adherence, quality of life, satisfaction Health economic evaluations

Blood and Lymphatic Cancer: Targets and Therapy (BLC:TT) is :-

• International, Peer-Reviewed, Open Access, Refereed, improved outcomes, enhanced survival, quality of life, Epidemiology, detection, Cellular research and biomarkers, Identification of biotargets, combination therapies, Patient adherence, satisfaction , Online , Continuously Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 1179-9889, Established: 2011, Impact Factor: 4.0
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE